Post by jurystillout on Nov 18, 2015 11:51:13 GMT -5
I'm a long investor, in at 5.92. I haven't sold a single share and won't for under $25. My MNKD shares are in my risky IRA. I have index funds for the money I am truly counting on for retirement. Here's the letter I sent to Matt this morning. If he responds to one or more of the questions, I will share unless he specifically asks me not to or there is non-disclosure statement on the response.
Matt,
I’m one of your many faithful, but very perplexed, and very underwater investors. There are some very straightforward questions that never seem to be directly addressed. I know you may not have the time to address me directly, but I want you to know what we investors are wanting to know.
1. Why do you allow the endless stream of co-ordinated hit-articles from Motley Fool & Adam F. to be quickly followed by HFT to drive the price down when your stock is constaintly on the Failed to Deliver list?
2. Why doesn’t Al Mann put an end to bankruptcy speculation by a quick press release:
“I’ve invested well over a billion dollars bringing this revolutionary drug to diabetics. I will not let outside forces who are afraid of this revolution to put the financing of Mannkind at risk.”
3. Why don’t you ask Sanofi to release a one line statement to the press:
“We are fully behind Afrezza. It is a core component of our future plans. Television commercials will commence as soon as xx% of insurance providers provide tier 2 coverage. We are working on a label change, which will happen soon. We are working on a superiority study which will start on (date) and include a double-blind study with (x) patients.”
4. Our pain medication trials with (partner) will begin on (date).
5. Our pulmonary hypertension trials with (partner) will begin on (date).
6. Alphabet will be providing contact lens based realtime glucose monitoring, a health tracker phone application and we will provide a smart dosage inhaler to completely revolutionize management of diabetes.
7. TEVA will be testing (x) new generic drugs delivered via Technosphere. Trials will begin on (date).
8. Sanofi has (x) number of sales reps visiting (x) number of doctors a week.
9. The reason scripts have inexplicably remained near 500 is (x). This number will grow immediately because of (x) and (x) and (x).